25.04.2013
- In the first quarter 2013, Lonza's business performance was solid and in line with expectations. While the Specialty Ingredients market segment showed a good performance, the...
25.04.2013
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that their new cGMP custom biopharmaceutical manufacturing 'biologics...
25.04.2013
- Laboratory equipment maker Thermo Fisher Scientific, which this month agreed to acquire Life Technologies for more than $13 billion, on Wednesday reported a higher-than-expected...
24.04.2013
- Amgen on Tuesday reported first-quarter sales that fell short of Wall Street expectations for most of its biggest-selling medicines, and its shares fell more than 6%. Revenue for...
24.04.2013
- AquaBounty Technologies expects regulatory approval by the fourth quarter of this year to produce its controversial genetically engineered salmon, its chief executive said on...
22.04.2013
- AstraZeneca is to pay privately held Bind Therapeutics as much as $200 million to develop a cancer medicine using the U.S. biotech company's nanotechnology drug delivery system...
18.04.2013
- Actelion shareholders rejected a $5.6 million pay award for the biotechnology company's chief executive Jean-Paul Clozel on Thursday, making it the second Swiss company in as many...
18.04.2013
- Syngenta, the world's largest maker of crop chemicals, expects farmers to continue to invest in products to boost agricultural output despite a recent drop in commodity prices...
